Inhibrx Biosciences | 8-K: Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
8-K: Current report
S-1: General form for registration of securities under the Securities Act of 1933
Inhibrx Biosciences | 8-K: Current report
Inhibrx Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Inhibrx Biosciences | 8-K: Current report
No Data
No Data